The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design. [electronic resource]
Producer: 20160711Description: 496 p. digitalISSN:- 1745-6215
- Administration, Oral
- Blood Glucose -- drug effects
- China -- epidemiology
- Combined Modality Therapy
- Cost-Benefit Analysis
- Diabetes Mellitus, Type 2 -- blood
- Disease Progression
- Double-Blind Method
- Drug Costs
- Drugs, Chinese Herbal -- administration & dosage
- Female
- Health Knowledge, Attitudes, Practice
- Humans
- Hypoglycemic Agents -- administration & dosage
- Incidence
- Male
- Middle Aged
- Patient Education as Topic -- economics
- Prediabetic State -- blood
- Risk Reduction Behavior
- Tablets
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.